Literature DB >> 13934699

The saga of thalidomide. Neuropathy to embryopathy, with case reports of congenital anomalies.

G W MELLIN, M KATZENSTEIN.   

Abstract

Entities:  

Keywords:  PHOCOMELIA; THALIDOMIDE

Mesh：

Substances：

Year:  1962        PMID： 13934699     DOI： 10.1056/NEJM196212062672305

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

Review 1.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

2.  Prospective survey of use of therapeutic drugs, alcohol, and cigarettes during pregnancy.

Authors:  P C Rubin; G F Craig; K Gavin; D Sumner
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-11

3.  High-throughput identification of small molecules that affect human embryonic vascular development.

Authors:  Helena Vazão; Susana Rosa; Tânia Barata; Ricardo Costa; Patrícia R Pitrez; Inês Honório; Margreet R de Vries; Dimitri Papatsenko; Rui Benedito; Daniel Saris; Ali Khademhosseini; Paul H A Quax; Carlos F Pereira; Nadia Mercader; Hugo Fernandes; Lino Ferreira
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

Review 4.  Teratogenic effects of thalidomide: molecular mechanisms.

Authors:  Takumi Ito; Hideki Ando; Hiroshi Handa
Journal:  Cell Mol Life Sci       Date:  2011-01-05       Impact factor: 9.261

5.  Chemical stabilities and biological activities of thalidomide and its N-alkyl analogs.

Authors:  Colleen Goosen; Timothy J Laing; Jeanetta du Plessis; Theunis C Goosen; Tharaknath B Rao; Gordon L Flynn
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

6.  Magnetic resonance imaging for monitoring the effects of thalidomide on experimental human breast cancers.

Authors:  Clemens C Cyran; Barbara Sennino; Bundit Chaopathomkul; Yanjun Fu; Victor S Rogut; David M Shames; Michael F Wendland; Donald M McDonald; Robert C Brasch
Journal:  Eur Radiol       Date:  2008-07-30       Impact factor: 5.315

7.  Use of thalidomide to diminish growth velocity in a life-threatening congenital intracranial hemangioma.

Authors:  Melissa Frei-Jones; Robert C McKinstry; Arie Perry; Jeffrey R Leonard; Tae Sung Park; Joshua B Rubin
Journal:  J Neurosurg Pediatr       Date:  2008-08       Impact factor: 2.375

8.  Immunomodulatory Agents with Antivascular Activity in the Treatment of Non-Small Cell Lung Cancer: Focus on TLR9 Agonists, IMiDs and NGR-TNF.

Authors:  Angelo Corti; Monica Giovannini; Carmen Belli; Eugenio Villa
Journal:  J Oncol       Date:  2010-06-03       Impact factor: 4.375

9.  Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity.

Authors:  L G Corral; G W Muller; A L Moreira; Y Chen; M Wu; D Stirling; G Kaplan
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

Review 10.  VEGF inhibitors and prostate cancer therapy.

Authors:  Jeanny B Aragon-Ching; William L Dahut
Journal:  Curr Mol Pharmacol       Date:  2009-06       Impact factor: 3.339
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.